# Study Evaluating Subjects With Distal Renal Tubular Acidosis

> **NCT03644706** · PHASE3 · TERMINATED · sponsor: **Advicenne Pharma** · enrollment: 3 (actual)

## Conditions studied

- Distal Renal Tubular Acidosis

## Interventions

- **DRUG:** ADV7103
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03644706
- **Lead sponsor:** Advicenne Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-20
- **Primary completion:** 2023-12-20
- **Final completion:** 2023-12-20
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Research operation issues
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03644706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03644706, "Study Evaluating Subjects With Distal Renal Tubular Acidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03644706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*